ReviewNaunyn-Schmiedeberg's archives of pharmacology2026
Role of gallic acid in the management of diabetes and its complications.
Review in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes is characterized by increased blood glucose levels (hyperglycemia) linked with insufficient insulin secretion or action. Diabetes has become a major health concern in the twenty-first century. Persistent hyperglycemia damages the kidneys, nerves, eyes, and heart. Furthermore, cardiovascular problems such as hypertension, abnormal lipoprotein concentrations, and cerebrovascular disease are more common in diabetic patients. Looking at the limitations of current diabetes treatment and associated complications, such as nephropathy, retinopathy, and cardiomyopathy, the approach of exploring plant bioactive compounds as an alternative therapeutic option has gained prime importance. Gallic acid is one of the important natural products that has been extensively studied for its various pharmacological effects. Emerging evidence suggests gallic acid modulates key pathways involved in glucose metabolism and oxidative stress, offering a multi-targeted approach to mitigate diabetic complications. The present review focuses on scientific studies carried out on gallic acid for its effect on diabetes and diabetic complications.
Indexed as
Identifiers
41324662What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.